glutathione for parkinson's patients therapy parkinson' Disease: Current Treatment Modalities and Emerging Therapies Revamping Parkinson's disease therapy using – facts about glutathione and parkinson's

Collagen and extracellular matrix: GHK-Cu upregulates genes encoding collagen I, collagen III, elastin, decorin, and other extracellular matrix components that provide structural support to skin

Cycling strategies and break protocols The GHK-Cu discontinuation profile suggesting gradual benefit decline without rebound effects creates opportunity for cycling strategies potentially offering benefits including reduced long-term cost through intermittent rather than continuous product purchase, decreased skin adaptation risk by preventing tolerance to copper peptide stimulation, improved treatment responsiveness when restarting after breaks allowing periodic benefit surges, and psychological flexibility avoiding dependency mindset from continuous indefinite use requirements

I can't wait for the final results

Your doctor may need to adjust the dosages of your drugs or keep a close eye on you to check for any unwanted effects